10zyme
PrivateLast Round
Accelerator
Nov 30, 2021
Total Funding Raised
$2,700
Momentum
Top 25%
of companies Caplight tracks
Company Overview
10zyme operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Accelerator round in November 2021.
10zyme is a medical technology company developing a point-of-care self-test diagnostic for high-risk human papillomavirus (HPV) to improve cervical cancer screening accessibility.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
10zyme Comparables
Compare 10zyme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| En Carta Diagnostics | 71% | |
| Teal Health | 71% | |
| Halodoc | 69% |
For institutional investors. Book with your work email.
10zyme Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
10zyme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Research Horizons | Accelerator |
| University of Edinburgh | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 217% MoM, from 1.3K to 4K.
- Jun 18, 2026
Monthly visitors increased 67% MoM, reaching 2.6K.
For institutional investors. Book with your work email.
10zyme Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 10zyme's valuation, stock price, and market status.
Is 10zyme a public or private company?
10zyme is a private company.
What is the current stock price of 10zyme?
10zyme is a private company, so its shares have no public market price. Caplight tracks 10zyme's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 10zyme worth (valuation)?
Valuation information for 10zyme is not publicly available.
Can I buy 10zyme stock?
10zyme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 10zyme's last funding round?
10zyme's most recent funding round was Accelerator on November 30, 2021.
Who are the main investors in 10zyme?
Key investors in 10zyme include Cancer Research Horizons, University of Edinburgh.
Will 10zyme IPO soon?
No public IPO plans have been announced for 10zyme.
How can I track 10zyme secondary market activity?
Caplight tracks bids, offers, and trades in 10zyme's shares on secondary markets.